Evidence map›Paper›PMID 40521380›Full record

ArticleBioinformatics advances2025

Next-generation sequencing-based tools or nanopore-based tools: which is more suitable for short tandem repeats genotyping of nanopore sequencing?

Wei Han, Xuemei Zhang, Qingzhen Zhang, Zhe Zhou

Abstract read
In one paragraph

Article in Bioinformatics advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. STRspy2.0: Unlocking the Potential of Long Reads for Forensic DNA Profiling.International journal of molecular sciences · 2026
    Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei HanBioinformatics Center of AMMS, Beijing 100850, P.R. China.
Xuemei ZhangKey Laboratory of Epigenetic Regulation and Intervention, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, P.R. China.
Qingzhen ZhangBioinformatics Center of AMMS, Beijing 100850, P.R. China.
Zhe ZhouBioinformatics Center of AMMS, Beijing 100850, P.R. China.ORCID https://orcid.org/0000-0003-4616-0467

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Motivation: Short tandem repeats (STRs) are widely recognized as critical genetic markers for individual identification. Nanopore sequencing technology holds promise as an effective tool for onsite STR detection owing to its portability. Initially, low sequencing quality led to the development of various genotyping tools specifically tailored for nanopore data. However, recent advancements in nanopore sequencing quality suggest that tools designed for next-generation sequencing (NGS) may be more suitable for analyzing nanopore data than those specifically developed for nanopore sequencing. Results: We selected two sequencing platforms, MinION Mk1C, and PolySeqOne, to generate sequencing data from 61 unrelated individual samples. Samples were amplified using a custom NanoSTR panel that included 31 autosomal STRs (A-STRs) and 31 Y chromosomal STRs (Y-STRs). Sequencing data were analyzed using four distinct tools: NASTRA, STRspy, STRinNGS, and STRait Razor. Our findings indicated that STRinNGS showed greater accuracy for both A-STRs and Y-STRs, enabling the accurate detection of a broad range of STRs. Compared with STRinNGS, NASTRA exhibited greater STR depth and featured more non-integer stutters. Therefore, in practical applications, STRinNGS demonstrates high reliability in genotyping. Availability and implementation: NASTRA, STRspy, STRinNGS and STRait Razor, which can be accessed via the following links: https://github.com/renzilin/NASTRA, https://github.com/unique379r/strspy, https://bitbucket.org/rirgabiss/strinngs/src/master, and https://github.com/Ahhgust/STRaitRazor, respectively. The commands during process are provided as requested by the corresponding author.

Identifiers

PMID40521380
PMCPMC12167636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.